Your browser doesn't support javascript.
loading
Intact multi-attribute method (iMAM): A flexible tool for the analysis of monoclonal antibodies.
Carillo, Sara; Criscuolo, Angela; Füssl, Florian; Cook, Ken; Bones, Jonathan.
Afiliación
  • Carillo S; National Institute for Bioprocessing Research and Training, Characterisation and Comparability Laboratory, Foster Avenue, Mount Merrion, A94 X099. Blackrock, Co. Dublin, Ireland.
  • Criscuolo A; Thermo Fisher Scientific, Im Steingrund 4-6, 63303 Dreieich, Germany.
  • Füssl F; National Institute for Bioprocessing Research and Training, Characterisation and Comparability Laboratory, Foster Avenue, Mount Merrion, A94 X099. Blackrock, Co. Dublin, Ireland.
  • Cook K; Thermo Fisher Scientific, Stafford House, 1 Boundary Park, Hemel Hempstead, HP2 7GE, United Kingdom.
  • Bones J; National Institute for Bioprocessing Research and Training, Characterisation and Comparability Laboratory, Foster Avenue, Mount Merrion, A94 X099. Blackrock, Co. Dublin, Ireland; School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland. Electron
Eur J Pharm Biopharm ; 177: 241-248, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35840072
ABSTRACT
The availability of rapid methods that can accurately define and quantify biopharmaceutical critical quality attributes has been the driving force for the implementation of mass spectrometry techniques throughout the development and production pipeline. While the multi-attribute method (MAM) has become widely adopted and developed, some critical information cannot be monitored through this workflow, such as correct chain assembly or the presence of fragments or aggregates. In this study, we combine intact protein mass spectrometry and the multi-attribute method to create an intact multi-attribute method - or iMAM. Using a CFR Part 11 compliant data system, we evaluated the proposed workflow using several intact analysis approaches under both denaturing and native conditions. As for the standard MAM approach, iMAM involves the generation of an intact protein target workbook which is created from the analysis of a reference sample, with ID confirmation obtained from deconvolution results and chromatographic retention times, while quantitation is obtained from the intensities of the m/z of most abundant charge states. The created processing method is then applied to the analysis of subsequent samples. New peak detection can also be performed, monitoring the number of components revealed after each analysis. The entire data process can be automated to generate a report within the chromatography data system software. Three case studies presented herein show the potential of iMAM for implementation at different stages of the production pipeline, from product development to stability testing and batch release.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irlanda